Published at Biotechx Europe 2025, this new solution is dedicated to accelerating research, clinical trial design and regulatory processes.
Expert.ai is a leading provider of enterprise artificial intelligence solutions for business value creation, and has announced a new AI-driven offering designed to accelerate innovation across the pharmaceutical, healthcare and life science industries. New solutions launched at Biotechx Europe 2025, Europe's largest parliament specializing in Pharma & Healthcare, allow organizations to enhance data analytics, streamline discovery processes and unlock new possibilities for clinical trials and treatment improvements.
Preparation for eix-submission It will allow your team to build smarter and more efficient workflows for regulatory documents.
EIX-Preclinical Document Intelligence Increase speed and accuracy to streamline preclinical documents, and free experts to focus on innovation.
EIX-Clinical Trials Intelligence By digging into the mountains of content from clinical registrations, scientific publications and real-world data, it helps the research team distill the most accurate and up-to-date information.
EIX-IP detection Provides comprehensive and explainable insights through patents, scientific literature and clinical trial data.
Also Read: Aithority Interview with Speakup CEO Tim Morrs
Experts by leveraging deep domain expertise and a unique hybrid AI approach. By reducing manual effort and scaling insights from the vast amount of data, the new solution uses the most effective AI technology to ensure regulatory accuracy, improve trial design, accelerate patient recruitment, reduce costs, and minimize the constant risk of delays.
“We are extremely proud of this new product for Pharma & Life Sciences. This represents a key advancement in our mission to leverage AI to make a meaningful impact in these industries.” “Our enhanced solutions are designed to reduce complexity, increase scientific and regulatory accuracy, and to focus on the most important innovations for free experts. We are ready to bring automation, explanation, and traceability from our research documents to every step.
With these innovations, Expert.AI continues to set standards for applying AI to Pharma & Life Sciences, providing more efficiency and reliability across the life science value chain through intelligent document automation and AI agents.
Also Read: Cognitive Product Design: Enhance the Power of Non-Technical Users through Natural Language Interaction with AI-Native PLM
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
